Argonaute RNA
$2.2M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Argonaute RNA is currently valued at $11.6M as of July 17, 2024. The company has raised a total of $5.5M in funding.
Capital Efficiency
With a capital efficiency ratio of 2.09x, Argonaute RNA has achieved a valuation that is 2.09 times the total capital raised. This metric indicates moderate capital efficiency.
Investment Perspective
Argonaute RNA's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Argonaute RNA Worth in 2025?
As of 2025, Argonaute RNA is valued at $11.6M, based on the company's Later Stage VC funding round in July 17, 2024. This valuation positions Argonaute RNA as one of the leading private companies in the sector.
Argonaute RNA Valuation History
Argonaute RNA's funding history demonstrates steady growth and investor confidence.
How Argonaute RNA Valuation is Determined
Private company valuations like Argonaute RNA's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Argonaute RNA Valuation FAQs
Is Argonaute RNA profitable?
Argonaute RNA has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Argonaute RNA's valuation compare to competitors?
Argonaute RNA is valued at $11.6M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Argonaute RNA IPO?
Argonaute RNA has not announced plans for an initial public offering. Until an IPO, investors can access Argonaute RNA shares through secondary market platforms.